STUDY: GENERICS BOOST PATIENT ADHERENCE

APRIL 01, 2006

Although the generics industry promotes its products as therapeutically identical to higher-priced brand name drugs, newly published research now suggests that patient adherence to a therapeutic regimen is higher for patients on generics rather than branded drugs. The study, published in the February 13, 2006, issue of the journal Archives of Internal Medicine, concluded that patients given the generic version of a drug were found to adhere to their treatments better than those prescribed the brand name versions. "After controlling for patient sociodemographic characteristics and drug class, [the proportion of days covered] was 12.6% greater for patients initiated on generic medications," the researchers concluded.




SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.